Your browser doesn't support javascript.
loading
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab.
Seban, Romain-David; Arnaud, Emilie; Loirat, Delphine; Cabel, Luc; Cottu, Paul; Djerroudi, Lounes; Hescot, Segolene; Loap, Pierre; Bonneau, Claire; Bidard, Francois-Clement; Huchet, Virginie; Jehanno, Nina; Berenbaum, Arnaud; Champion, Laurence; Buvat, Irene.
Afiliação
  • Seban RD; Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 92210, Saint-Cloud, France. romaindavid.seban@curie.fr.
  • Arnaud E; Laboratoire d'Imagerie Translationnelle en Oncologie, Inserm U1288, Institut Curie, PSL University, Paris Saclay University, 91400, Orsay, France. romaindavid.seban@curie.fr.
  • Loirat D; Department of Medical Oncology, Institut Curie, PSL Research University, 75005, Paris, France.
  • Cabel L; Department of Medical Oncology, Institut Curie, PSL Research University, 75005, Paris, France.
  • Cottu P; Department of Medical Oncology, Institut Curie, PSL Research University, 75005, Paris, France.
  • Djerroudi L; Department of Medical Oncology, Institut Curie, PSL Research University, 75005, Paris, France.
  • Hescot S; Department of Pathology, Institut Curie, 75005, Paris, France.
  • Loap P; Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 92210, Saint-Cloud, France.
  • Bonneau C; Department of Radiation Oncology, Institut Curie, 92210, Saint-Cloud, France.
  • Bidard FC; Inserm U900, Institut Curie, 35, rue Dailly, 92210, Saint-Cloud, France.
  • Huchet V; Department of Surgery, Institut Curie, 92210, Saint-Cloud, France.
  • Jehanno N; Department of Medical Oncology, Institut Curie, UVSQ/Paris-Saclay University, 92210, Saint-Cloud, France.
  • Berenbaum A; Circulating Tumor Biomarkers Laboratory, Institut Curie, SiRIC, PSL Research University, Paris, France.
  • Champion L; Department of Nuclear Medicine, Institut Curie, 75005, Paris, France.
  • Buvat I; Department of Nuclear Medicine, Institut Curie, 75005, Paris, France.
Eur J Nucl Med Mol Imaging ; 50(13): 4024-4035, 2023 11.
Article em En | MEDLINE | ID: mdl-37606858
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Ano de publicação: 2023 Tipo de documento: Article